Jun Ho Yi, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAgedAlemtuzumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useDrug Resistance, NeoplasmFemaleHumansLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/pathologyLymphoma, Mantle-Cell/drug therapyLymphoma, Mantle-Cell/pathologyMaleMiddle AgedNeoplasm Recurrence, Local/drug therapyNeoplasm Recurrence, Local/pathologyPilot ProjectsSalvage TherapySurvival RateTreatment OutcomeYoung Adult
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAlemtuzumab
Year: 2010 PMID: 21067447 DOI: 10.3109/10428194.2010.529203
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022